Literature DB >> 12944914

Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.

Valentina Sirri1, Marie Pierre Leibovitch, Serge Alexandre Leibovitch.   

Abstract

Rhabdomyosarcoma (RMS) has deregulated proliferation and is blocked in the differentiation program despite Myf-5, MyoD and myogenin expression. Here we show that ectopic expression of MRF4, which is not subject to an autoregulatory pathway but regulated by the other MRFs protein family, induces growth arrest and terminal differentiation in RD cells. Deletion mapping identified a positive-acting C-terminal domain in MRF4 as the mediator of transcriptional activity, revealing a conserved motif with helix III in MyoD previously found to initiate expression of endogenous skeletal muscle genes. By using chimeric MyoD/MRF4 proteins, we observe that the C-terminal motif of MRF4 rescues MyoD activity in RD cells. Moreover, comparative induction of muscle-specific genes following activation of MyoD, through the expression of a constitutively activated MKK6 either in the absence or presence of MRF4, shows that MyoD and MRF4 can differently regulate muscle genes expression. Together, these results demonstrate that the MRF4 C-terminus functions as specification as well as activation domain in tumor cells. They provide a basis to identify gene products necessary for b-HLH-mediated differentiation versus tumor progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944914     DOI: 10.1038/sj.onc.1206690

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

Review 1.  Myogenic regulatory factors: The orchestrators of myogenesis after 30 years of discovery.

Authors:  Hasan A Asfour; Mohammed Z Allouh; Raed S Said
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-07

Review 2.  Childhood rhabdomyosarcoma: recent advances and prospective views.

Authors:  C Wang
Journal:  J Dent Res       Date:  2011-09-13       Impact factor: 6.116

3.  Comparison of genome-wide binding of MyoD in normal human myogenic cells and rhabdomyosarcomas identifies regional and local suppression of promyogenic transcription factors.

Authors:  Kyle L MacQuarrie; Zizhen Yao; Abraham P Fong; Scott J Diede; Erin R Rudzinski; Douglas S Hawkins; Stephen J Tapscott
Journal:  Mol Cell Biol       Date:  2012-12-10       Impact factor: 4.272

4.  The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation.

Authors:  A N Gerber; C W Wilson; Y-J Li; P-T Chuang
Journal:  Oncogene       Date:  2006-09-11       Impact factor: 9.867

5.  Expression of myogenic regulatory factors in the muscle-derived electric organ of Sternopygus macrurus.

Authors:  Jung A Kim; Christine Laney; Jeanne Curry; Graciela A Unguez
Journal:  J Exp Biol       Date:  2008-07       Impact factor: 3.312

6.  Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma.

Authors:  Anja Uhmann; Hannah Niemann; Bérénice Lammering; Cornelia Henkel; Ina Heß; Albert Rosenberger; Christian Dullin; Anke Schraepler; Walter Schulz-Schaeffer; Heidi Hahn
Journal:  Sarcoma       Date:  2012-02-21

7.  p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.

Authors:  Carmela Ciccarelli; Francesco Marampon; Arianna Scoglio; Annunziata Mauro; Cristina Giacinti; Paola De Cesaris; Bianca M Zani
Journal:  Mol Cancer       Date:  2005-12-13       Impact factor: 27.401

8.  Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.

Authors:  Julie Lagirand-Cantaloube; Karen Cornille; Alfredo Csibi; Sabrina Batonnet-Pichon; Marie Pierre Leibovitch; Serge A Leibovitch
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

9.  Downregulation of POFUT1 Impairs Secondary Myogenic Fusion Through a Reduced NFATc2/IL-4 Signaling Pathway.

Authors:  Audrey Der Vartanian; Julien Chabanais; Claire Carrion; Abderrahman Maftah; Agnès Germot
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.